Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

CDK activation by non-cyclin proteins.

Angel R Nebreda¹

¹CNIO (Spanish National Cancer Center), Melchor Fernández Almagro 3, E-28029 Madrid, Spain.

Current Opinion in Cell Biology

|February 21, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Targeting p38α in cancer: challenges, opportunities, and emerging strategies.

Molecular oncology·2026

Same author

The PIN1-p38-CtIP signalling axis protects stalled replication forks from deleterious degradation.

Nucleic acids research·2025

Same author

Structural basis of a redox-dependent conformational switch that regulates the stress kinase p38α.

Nature communications·2023

Same author

Dual deletion of guanylyl cyclase-A and p38 mitogen-activated protein kinase in podocytes with aldosterone administration causes glomerular intra-capillary thrombi.

Kidney international·2023

Same author

Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway.

Nature communications·2023

Same author

Characterization of p38α Signaling Networks in Cancer Cells Using Quantitative Proteomics and Phosphoproteomics.

Molecular & cellular proteomics : MCP·2023

Same journal

Mechanosensing in immune cells: Implications for migration and beyond.

Current opinion in cell biology·2026

Same journal

Emerging role of organelles in cell migration.

Current opinion in cell biology·2026

Same journal

Nuclear adaptation in cell migration.

Current opinion in cell biology·2026

Same journal

Patterns in motion: Choreographing dynamic cell behaviours during tissue repair.

Current opinion in cell biology·2026

Same journal

Quo vadis reconstituted cell surfaces? Purpose and future perspectives for minimal systems of the cell plasma membrane.

Current opinion in cell biology·2026

Same journal

Nuclear determinants of mRNA and protein isoforms.

Current opinion in cell biology·2026

See all related articles

Cell cycle progression relies on cyclin-dependent kinases (CDKs) and their activators. Mammalian RINGO/Speedy proteins were found to directly activate Cdk1 and Cdk2, offering new insights into cell cycle regulation.

Area of Science:

Cell Biology
Molecular Biology
Biochemistry

Background:

Cell cycle progression is tightly regulated by cyclin-dependent kinases (CDKs) and their activating partners, cyclins.
Cyclins control CDK activity through periodic synthesis and degradation.
Alternative CDK activators exist, lacking sequence similarity to cyclins.

Purpose of the Study:

To investigate the role of RINGO/Speedy proteins as alternative activators of CDKs.
To characterize the interaction between mammalian RINGO/Speedy proteins and CDKs.

Main Methods:

Identification and characterization of mammalian RINGO/Speedy family members.
Biochemical assays to assess the binding and activation of Cdk1 and Cdk2 by RINGO/Speedy proteins.

Related Experiment Videos

Main Results:

Five mammalian RINGO/Speedy family members were identified.
All identified RINGO/Speedy proteins directly bind to and activate Cdk1 and Cdk2.
RINGO/Speedy proteins represent a novel class of CDK activators.

Conclusions:

Mammalian RINGO/Speedy proteins are direct activators of Cdk1 and Cdk2.
These proteins offer an alternative pathway for CDK activation, independent of cyclins.
Further research into RINGO/Speedy proteins may reveal new therapeutic targets for cell cycle-related disorders.